State Regulations Contact Us Site Map      
Ortho-McNeil Pharmaceutical, Inc
Home
About Us
Our Products
News Center
Professional Resources
Our Giving
Medical Education
Health Info Center
Women's Health
Bladder Health
DITROPAN XL® (oxybutynin chloride) Extended-Release Tablets

DITROPAN XL is indicated for the treatment of overactive bladder with symptoms of urge incontinence episodes (wetting accidents), urgency (a strong need to urinate), and frequency (urinating often).

DITROPAN XL was the first once-a-day medication for overactive bladder. It has been proven to significantly reduce wetting accidents caused by overactive bladder. Due to its patented OROS® technology, just 1 tablet releases medication into your system continuously for up to 24 hours. DITROPAN XL is available in 5 mg, 10 mg and 15 mg strength tablets.

>> Full US Prescribing Info

Important Safety Information
DITROPAN XL is generally well tolerated. Common side effects were dry mouth, constipation, drowsiness, headache, blurred vision, dizziness, diarrhea, and nausea. In clinical tests, 6.8% of patients discontinued use due to side effects.

Heat stroke and fever due to decreased sweating in hot temperatures have been reported.

People with certain types of stomach, urinary, or glaucoma problems should not take DITROPAN XL. People who currently take medication for a gastrointestinal disorder or have had a gastrointestinal blockage, should discuss with their healthcare professional if once-a-day DITROPAN XL is right for them.

Tablets must be swallowed whole with the aid of liquids, and must not be chewed, divided, or crushed.

Please click here for full Prescribing Information.


Key Products
DITROPAN XL®
ELMIRON® Capsules
All Bladder Health Products


DITROPAN XL® product shot


View Full US Prescribing Information
(Download Adobe Acrobat Reader)